NOVARTIND.NS

Novartis India Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,388.90

+1.29%Jun 19, 2026

AI Brief

Market cap

$37.35B

52w range

—

P / E

—

EPS · FY 2026

$37.74

Volume

—

Revenue · FY 2026

$3.54B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Novartis India Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1388.90

Change

+38.88%

Period high

$1536.00

Period low

$957.95

Period start

$1000.102026-04-06

Through 2026-06-19

Fair value

Football field →

Weighted blend

$693.74

— vs spot

Recommendation

n/a

4 of 4 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

NOVARTIND.NS

1,389+38.88%

H 1,588L 952.10MA50 1,200MA200 —Avg vol 29K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Technology
+2.51%
Industrials
+1.00%
Basic Materials
+0.65%
Energy
+0.59%
Financial Services
+0.23%
Healthcare
-0.18%
Communication Services
-0.18%
Consumer Defensive
-0.30%
Consumer Cyclical
-0.85%
Real Estate
-0.99%
Utilities
-1.03%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-1.01%
Software - Services
+9.60%
Broadcasting
+8.34%
Medical - Equipment & Services
+5.08%
Computer Hardware
+4.56%
Financial - Mortgages
+4.08%
Staffing & Employment Services
-3.62%
Internet Content & Information
+3.58%
Coal
-3.56%
Oil & Gas Energy
-3.54%
Biotechnology
+3.28%
Electrical Equipment & Parts
+3.27%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for NOVARTIND.NS.

Financial scores

DBJun 23, 2026

Altman Z

12.67

Safe

≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress

Piotroski F

5/9

Average

≥ 7 strong · 4–6 average · < 4 weak

Peers

No peer list available for NOVARTIND.NS.

Total assets

$9.78B

Total debt

$32.1M

Cash & equiv

$6.68B

Operating CF

$847M

Free cash flow

$843.6M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$3.54B	$921.5M	$931.8M	$37.74	+26.30%